AUSTIN, Tex., April 26, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company, today announced it will…
CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that the…
Seamless, Comprehensive Capabilities Eliminate Barriers to Microbiome ResearchRENSSELAER, N.Y., April 26, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader…
Company continues innovating preclinical tools used in new and ongoing small animal research and product development with SmartStudy™ SmartStudy Technology…
Tampa, April 26, 2022 (GLOBE NEWSWIRE) -- Alcohol Awareness Month began in 1987 and was formerly funded through the National…
Four ARVO presentations accepted will feature data from APX3330 Phase 2b trial in Diabetic Retinopathy and Nyxol® Phase 2 trial…
Gold Award Recognizes Antibody TestRARITAN, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's…
Minerva calls on women to talk about their periodsSANTA CLARA, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc.…
DUBLIN, Ireland and BRIDGEWATER, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today its partner HLS…
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…